Kristen M. Coleman, RN, BSN, Stella M

Slides:

Advertisements

Similar presentations

Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft.

Advertisements

Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review

A Pilot Trial of Unrelated Cord Blood Transplantation (UCBT) and Unmatched Human Placental Derived Stem Cells (HPDSC) in Children and Young Adults with.

How to Treat MDS without Stem Cell Transplantation

Assessment of Safety and Efficacy of Peripheral Blood Stem Cell (PBSC) Mobilization with G-CSF in Haploidentical Maternal Donors with Sickle Cell Trait.

Microsoft Access®: A Viable Blood and Marrow Transplant (BMT) Database Solution Lindsay Dozeman, Alison Amendola, MHA, Connie Grobe, Lisa Cantwell, MHA,

Biology of Blood and Marrow Transplantation

Improvement in Hematopoiesis with Treatment of Iron Overload Following Allogeneic Transplants Akash Mukherjee, MD, Dhaval Shah, MD, Gloria Obi, PhD,

Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Is Associated with Reduced Hospital Days and Utilization of Opiate Infusion and Total Parenteral.

Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addback in Children, Adolescents & Adults with.

Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia Katerina Ancevski,

Vitamin A Deficiency Is Associated with Increased Risk of Acute Graft Versus Host Disease in Children Dana T. Lounder, MD, Sonata Jodele, MD, Pooja Khandelwal,

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

Impact of Pre-Transplant Minimal Residual Disease in Patients with AML Undergoing Myeloablative Cord Blood Transplantation Filippo Milano, MD, PhD, Brent.

A Pilot Study of Unrelated Cord Blood (UCB) Transplantation and Unmatched Human Placental Derived Stem Cells (HPDSC) in Pediatric Malignant and Non-Malignant.

Inhaled Cyclosporine Solution for the Treatment of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) or Lung Transplantation

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)

Gregory Wallace, DO, Sonata Jodele, MD, Kasiani C

A. Effect of Computerized Triage Support for Evaluation and Treatment of Febrile Bone Marrow Transplant Patients Who Present to the Emergency Department

Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants Ashley Teusink,

Biology of Blood and Marrow Transplantation

Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) Cynthia.

Jane Kempenich, Kelly Buck, John Hermanson, Jason Dehn, MPH

Early Soluble ST2 Elevation Predicts Future Left Ventricular Systolic Dysfunction after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Thomas D.

Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Abigail Pate, Mikako Warren,

Smartphrases: Streamlining Electronic Documentation of Patient Data for CIBMTR Reporting and Clinical Research Compliance Hannah E. Spencer, MSc, Amy.

More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors Jo-Anne H. Young, MD, Brent R. Logan,

Pauline A. Daniels, DO, Stella M

Pulse Cyclophosphamide for Steroid-Refractory Chronic Graft-Versus-Host Disease Nelson J. Chao, MD, MBA, Yevgeniya Gora Foster, MD, Krista Rowe, RN, MSN,

A Single Ultra High Dose of Vitamin D is Safe and Feasible in Early Peri-Transplant Period to Prevent Vitamin D Deficiency in Pediatric HSCT Recipients

Early Use of Inhaled Ribavirin Can Improve Outcomes in High Risk Hematopoietic Stem Cell Transplant and Leukemia Patients with RSV Infection Ron Mihelic,

Sleep: An Unrecognized Casualty of Stem Cell Transplant

Seth Joshua Rotz, Nathan Luebbering, Bradley P. Dixon, Christopher E

A Novel Strategy in Managing Post-Liver Transplant Acute Graft-Versus-Host-Disease: The New Era (T)Rojan Horse Zeyad Kanaan, MD, William Tse, MD, FACP

Priscila Badia, Heidi Andersen, David Haslam, Adam S

Hematopoietic Cell Transplantation for Acute Leukemia and Advanced Myelodysplastic Syndrome in Fanconi Anemia Richard Mitchell, Todd Defor, John E. Wagner,

Increased Vitamin D Binding Protein Levels Are Associated with Improved Overall Survival Following Bone Marrow Transplant in Children Nathan Luebbering,

Endothelial Injury, Neutrophil Extracellular Traps, and Complement Activation in Thrombotic Microangiopathy and GVHD Nicholas J. Gloude, Sonata Jodele,

Patient Self-Perceived Burden and Caregiver Burden in Recipients of Hematopoietic Stem Cell Transplantation: A Longitudinal Study Examining Gender Differences

Annelies Billen, Jasmin B. L

Potential Use of Human Placenta Derived Stem Cell (HPDSCs) As a Novel Stem Cell Source for the Treatment of Recessive Dystrophic Epidermolysis Bullosa.

Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing Benjamin.

Infection Prevention - Visitors and the Best of Intentions

Integrative Therapy Use as a Comfort Measure with BMT Patients

Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in.

A Successful Approach to Decreasing Central Line Associated Blood Stream Infections Colleen Butcher, RN, BSN, OCN, Cindy Kramer, RN, BSN, OCN, Carrie.

Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT Javier El-Bietar, MD, Mikako Warren, MD, Christopher.

Robust Donor Chimerism and Engraftment Following Familial Haploidentical (FHI) (CD34 Enriched and T-Cell Addback) Allogeneic Stem Cell Transplantation.

Sonata Jodele, Kejian Zhang, Christopher E. Dandoy, Kasiani C

ASBMT and CBMTG Release Choosing Wisely BMT Recommendations

Mohammad Alhyari, M. D. , Aymen Bukannan, M. D. , Kimberly Brown, M. D

Automated Production of Clinical-Grade CMV-Specific T Cells to Implement Immunotherapy at the Bedside Priti Tewari, MD, Pappanaicken R. Kumaresan, PhD,

September Mitchell, BSN, MHI, RN, CHTC, OCN, Sarah L

Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation

Does Cryopreserved Hematopoietic Stem Cell Product Need an Expiration Date? Recipients Engrafted Despite Infusion of Products over Five Years in Storage.

Renee C. Gresh, DO, E. Anders Kolb, MD, Corinna L

Management of Cytokine Release Syndrome (CRS) in Patients Undergoing Chimeric Antigen Receptor Modified (CAR) T-Cell Therapy Following Autologous Stem.

Blood and Marrow Transplant Handbook

Evaluation of a Data-Derived Algorithm for Preemptive Use of Plerixafor for Stem Cell Harvest in Patients Eligible for Autologous Stem Cell Transplant.

Higher Total Nucleated Cell Dose, but Not CD3+, 4+, 8+, or 34+ Cell Dose, Is Associated with Better Overall and Progression-Free Survival after Allogeneic.

Leading the Frontier: Successful Integration of an Adult BMT Hospital-Based Outpatient Practice Brenda Frye, PA-C, DHSc, Patricia McLean, APRN, CNP,

Mammen Chandy Biology of Blood and Marrow Transplantation

Heather A. Himburg, PhD, Liman Zhao, Jenny Kan, John P. Chute, M.D.

Identification of CD137+ IFN-g- CD4+ Alloreactive T Cells Post Myeloablative Double Cord Blood Transplant: A Synergistic Role in the Graft Verus Graft.

IL-8 Levels Early after Bone Marrow Transplant are Associated with Later Complications of Stem Cell Transplantation Nikhil Dole, Nathan Luebbering, Nicholas.

Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues? Seth Joshua Rotz, MD, Thomas D. Ryan,

Analysis of 402 Cord Blood Units to Assess Factors Influencing Infused Viable CD34+ Cell Dose: The Critical Determinant of Engraftment Duncan Purtill,

In Memoriam: E. Donnall Thomas

Cerebral Venous Thrombosis after Autologous Stem Cell Transplantation

Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory- Confirmed Bloodstream Infections after Stem Cell Transplantation Christopher.

Presentation transcript:

Sustaining a Standardized Cardiac Monitor Care Process to Reduce Nuisance Alarms Kristen M. Coleman, RN, BSN, Stella M. Davies, MBBS, PhD, Laura Flesch, MSN, RN, CRNP, Connie Koons, RNII BSN, Melissa Hayward, RN, BSN, CPN, Alero Olomajeye, CBET, Kathleen Marie Demmel, BSN, RN, MHA, Sonata Jodele, MD, Jodi Jacobs, CNP, Lori Ann McKenna, CNP, Chad Olson, CBET, Kimberly Shoemaker, BSN, Jessica Powers, BSN, Christopher E. Dandoy, MD, MSc Biology of Blood and Marrow Transplantation Volume 21, Issue 2, Pages S375-S377 (February 2015) DOI: 10.1016/j.bbmt.2014.11.613 Copyright © 2015 Terms and Conditions

Biology of Blood and Marrow Transplantation 2015 21, S375-S377DOI: (10 Biology of Blood and Marrow Transplantation 2015 21, S375-S377DOI: (10.1016/j.bbmt.2014.11.613) Copyright © 2015 Terms and Conditions

Biology of Blood and Marrow Transplantation 2015 21, S375-S377DOI: (10 Biology of Blood and Marrow Transplantation 2015 21, S375-S377DOI: (10.1016/j.bbmt.2014.11.613) Copyright © 2015 Terms and Conditions